Interleukin 22, a potential therapeutic target for rheumatoid arthritis

Journal of Rheumatology

Volumn 39, Issue 11, 2012, Pages 2220-2221

  Xie, Qiang ^a   Wang, Shi Cun ^b   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCITRIOL; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 22; MONOCYTE CHEMOTACTIC PROTEIN 1; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIBODY PRODUCTION; BONE EROSION; CANDIDA ALBICANS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; FIBROBLAST LIKE SYNOVIOCYTE; HUMAN; LETTER; NATURAL KILLER CELL; NONHUMAN; OSTEOCLASTOGENESIS; PANNUS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVIOCYTE; SYNOVITIS; TH17 CELL;

ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INTERLEUKINS; MALE;

EID: 84868349312     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120757     Document Type: Letter

References (12)

1. Da Rocha LF Jr, Duarte AL, Dantas AT, Mariz HA, Pitta ID, Galdino SL, et al. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J Rheumatol 2012;39:1320-5.
2. Kim KW, Kim HR, Park JY, Park JS, Oh HJ, Woo YJ, et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 2012;64:1015-23.
3. Mitra A, Raychaudhuri SK, Raychaudhuri SP. Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther 2012;14:R65.
4. Leipe J, Schramm MA, Grunke M, Baeuerle M, Dechant C, Nigg AP, et al. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2011;70:1453-7.
5. Zhang L, Li JM, Liu XM, Ma DX, Hu NW, Li YG, et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011;31:606-14.
6. Zhang L, Li YG, Li YH, Qi L, Liu XG, Yuan CZ, et al. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PloS One 2012;7:e31000.
7. Ren J, Feng Z, Lv Z, Chen X, Li J. Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-α. J Rheumatol 2011;38:2112-8.
8. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, et al. Expression of interleukin-22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine. Arthritis Rheum 2005;52:1037-46.
9. Marijnissen RJ, Koenders MI, Smeets RL, Stappers MH, Nickerson-Nutter C, Joostern LA, et al. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis Rheum 2011;63:2939-48.
10. Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld JC, et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 Mice. Arthritis Rheum 2009;60:390-5.
11. Colin EM, Asmawidjaja PS, van Hamburg IP, Mus AM, van Driel M, Hazes JM, et al. 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010;62:132-42.
12. van de Veerdonk FL, Lauwerys B, Marijnissen RJ, Timmermans K, Di Padova F, Koenders MI, et al. The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum 2011;63:1507-16.